By David Tuller, DrPH The other day, I posted yet another blog about Cochrane’s deeply flawed 2019 review of exercise therapy for what it called chronic fatigue syndrome (CFS), and the organization’s decision last December to abandon a planned update. Specifically, I was commenting on a response from the review’s lead author, Lillebeth Larun, to …Trial By Error: My Letter to Cochrane’s Chief Executive Officer Read More »| Virology Blog
By David Tuller, DrPH It’s hard to keep up with everything going on in this field these days. So I missed the fact that Lillebeth Larun, the lead author behind the deeply flawed Cochrane review of exercise therapies for what the organization then called chronic fatigue syndrome (CFS) has concocted yet another unconvincing defense of …Trial By Error: Cochrane CFS Exercise Review “May Not Apply” to Patients Diagnosed with Newer ME/CFS Definitions, Per Lead Author Read More »| Virology Blog
The other day, I posted yet another blog about Cochrane’s deeply flawed 2019 review of exercise therapy for what it called chronic fatigue syndrome (CFS), and the organization’s decision last December to abandon a planned update. Specifically, I was commenting on a response from the review’s lead author, Lillebeth Larun, to a comment from the […]| Trial By Error
By David Tuller, DrPH| Trial By Error
By David Tuller, DrPH This morning, I e-mailed the following letter to Dr Karla Soares-Weiser, Cochrane’s editor-in-chief, about the decision to abandon a p ...| Virology Blog
Nicola Baker| Trial By Error
By David Tuller, DrPH| Trial By Error
By David Tuller, DrPH| Trial By Error
By David Tuller, DrPH I have written frequently about Cochrane, the organization renowned for its systematic reviews of medical interventions, and its deepl ...| Virology Blog
By David Tuller, DrPH| Trial By Error
By David Tuller, DrPH Cochrane has just given the finger to the international ME/CFS community. After jerking everyone around and promising for five years t ...| Virology Blog